While few studies have directly assessed the relationship between PPA2 and risk of prostate cancer prospectively, a proteomic tissue analysis comparing men with localised prostate cancer to men with lymph node metastasised prostate cancer found significantly higher levels of PPA2 in men with the more advanced disease.51 Here, PPA2 is linked to prostate cancer.